DELIVERY ORDER

DOBSON DAVANZO & ASSOCIATES, LLC - EVALUATION OF THE INTRAVENOUS IMMUNE GLOBULIN DEMONSTRATION: THE PURPOSE OF THIS REQUIREMENT IS TO SECURE A QUALIFIED VENDOR TO DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION THAT INFORMS THE INTERMEDIATE AND FINAL REPORT TO CONGRESS (RTC). THIS EFFO

PIID: 75FCMC22F0007
Effective Date: Dec 22, 2021End Date: Closed on Jun 21, 2025
Award $
$1.8M
Vendor
DOBSON DAVANZO & ASSOCIATES, LLC

Key Details

Dollars Obligated
$1.8M
Awarding Sub-Agency
Centers for Medicare and Medicaid Services
Contract Vehicle
STARS III
Parent IDIQ (PIID)
47QRAA21D002Y

Description

EVALUATION OF THE INTRAVENOUS IMMUNE GLOBULIN DEMONSTRATION: THE PURPOSE OF THIS REQUIREMENT IS TO SECURE A QUALIFIED VENDOR TO DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION THAT INFORMS THE INTERMEDIATE AND FINAL REPORT TO CONGRESS (RTC). THIS EFFO

Context & Analysis

Department of Health and Human Services obligated $1,836,326 to DOBSON DAVANZO & ASSOCIATES, LLC for evaluation of the intravenous immune globulin demonstration: the purpose of this requirement is to secure a qualified vendor to design and carry out an independent evaluation that informs the intermed…. This award is one of several similar procurements from Department of Health and Human Services — related awards are listed below.

Contractor Information

View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related